Compare
biote Corp. vs Marimed Inc. vs Cronos Group Inc. vs Natural Alternatives International Inc
| Latest fiscal year | biote Corp. BTMD | Marimed Inc. MRMD | Cronos Group Inc. CRON | Natural Alternatives International Inc NAII |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2026-06-30 |
| Revenue | $192.22M | $159.83M | $146.59M | $142.51M |
| Revenue growth (YoY) | -2.5% | +1.3% | +24.6% | +9.7% |
| Gross margin | n/a | 36.2% | 42.8% | 6.3% |
| Operating margin | 18.5% | -1.8% | -11.9% | -13.2% |
| Net margin | 14.1% | -9.1% | -6.4% | -14.5% |
| Net income | $27.05M | -$14.48M | -$9.45M | -$20.70M |
| EPS (Diluted) | $0.74 | -$0.04 | -$0.02 | -$3.43 |
| Operating cash flow | $35.19M | $7.70M | $25.87M | -$8.92M |
| Free cash flow | $30.18M | $6.53M | $149.0K | -$12.62M |
| Cash & equivalents | $24.12M | n/a | $791.79M | $7.39M |
| Total assets | $107.61M | $202.56M | $1.20B | $126.45M |
| Total liabilities | $158.01M | $137.83M | $54.18M | $76.49M |
| Shareholders' equity | -$58.54M | $50.01M | $1.14B | $49.96M |
| Return on year-end equity | n/a | -29.0% | -0.8% | -41.4% |
| Shares outstanding | n/a | 396.91M | 381.59M | 6.27M |
Revenue, most recent five fiscal years
| Fiscal year | biote Corp. | Marimed Inc. | Cronos Group Inc. | Natural Alternatives International Inc |
|---|---|---|---|---|
| Latest | $192.22M Ended 2025-12-31 | $159.83M Ended 2025-12-31 | $146.59M Ended 2025-12-31 | $142.51M Ended 2026-06-30 |
| 1 year earlier | $197.19M Ended 2024-12-31 | $157.71M Ended 2024-12-31 | $117.61M Ended 2024-12-31 | $129.86M Ended 2025-06-30 |
| 2 years earlier | $185.36M Ended 2023-12-31 | $148.60M Ended 2023-12-31 | $87.24M Ended 2023-12-31 | $113.80M Ended 2024-06-30 |
| 3 years earlier | $164.96M Ended 2022-12-31 | $134.01M Ended 2022-12-31 | $86.75M Ended 2022-12-31 | $154.01M Ended 2023-06-30 |
| 4 years earlier | $139.40M Ended 2021-12-31 | $121.46M Ended 2021-12-31 | $64.56M Ended 2021-12-31 | $170.97M Ended 2022-06-30 |